Skip navigation

An app-based WHO mental health guide for depression detection: a cluster randomized clinical trial

An app-based WHO mental health guide for depression detection: a cluster randomized clinical trial

Kohrt, Brandon A., Ojagbemi, Akin, Luitel, Nagendra P., Bakolis, Ioannis, Bello, Toyin, Mccrone, Paul ORCID logoORCID: https://orcid.org/0000-0001-7001-4502, Taylor Salisbury, Tatiana, Jordans, Mark J. D., Votruba, Nicole, Carswell, Kenneth, Green, Eric, Gkaintatzi, Evdoxia, Lamichhane, Bishnu, Elugbadebo, Olufisayo, Kola, Lola, Lempp, Heidi, Chowdhary, Neerja, Dua, Tarun, Gureje, Oye and Thornicroft, Graham (2025) An app-based WHO mental health guide for depression detection: a cluster randomized clinical trial. JAMA Network Open, 8 (5):e2512064. ISSN 2574-3805 (Online) (doi:10.1001/jamanetworkopen.2025.12064)

[thumbnail of Open Access Article]
Preview
PDF (Open Access Article)
50687 McCRONE_An_App-Based_WHO_Mental_Health_Guide_For_Depression_Detection_A_Cluster_Randomized_Clinical_Trial_(OA)_2025.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Importance
Depression detection in primary care remains limited in low- and middle-income countries despite increasing use of the World Health Organization Mental Health Gap Action Programme–Intervention Guide (mhGAP-IG).
Objective
To test an app version of the mhGAP-IG (e-mhGAP-IG) in Nepal and Nigeria to improve depression detection.
Design, Setting, and Participants
In this feasibility cluster randomized clinical trial conducted from February 14, 2021, to March 25, 2022, primary care facilities (unit of clustering) in Nepal and Nigeria were randomized to the standard mhGAP-IG training arm (control) or to training using the e-mhGAP-IG app (intervention). Primary care workers (PCWs) received training based on the arm assignment of their health care facility. Statistical analysis was conducted from July 20, 2022, through September 27, 2024.
Intervention
Training using standard mhGAP-IG vs training using the e-mhGAP-IG.
Main Outcomes and Measures
Analysis was performed on an intention-to-treat basis. The main outcome was accuracy of depression detection rates by PCWs, evaluated prior to mhGAP training and 5 to 8 months after training, measured as the percentage of patients who received a depression diagnosis by their PCWs compared with the number of patients who scored 10 or more on the locally validated 9-item Patient Health Questionnaire. Costs per patient detected were calculated.
Results
In Nepal, 25 facilities (67 PCWs; mean [SD] age, 35.3 [9.2] years; 52 men [78%]) were randomized: 13 facilities to standard mhGAP-IG training (36 PCWs) and 12 facilities to e-mhGAP-IG (31 PCWs). In Nigeria, 10 facilities (47 PCWs; mean [SD] age, 46.9 [7.5] years; 44 women [94%]) were randomized: 5 facilities to standard mhGAP-IG (25 PCWs) and 5 facilities to e-mhGAP-IG (22 PCWs). In Nepal, depression detection by PCWs in the standard mhGAP-IG arm increased from 0 of 43 patients before training to 15 of 92 patients after training (adjusted mean change [AMC], 16% [95% CI, 5%-28%]), and depression detection in the e-mhGAP-IG arm increased from 0 of 49 before training to 22 of 91 after training (AMC, 24% [95% CI, 12%-36%]). In Nigeria, depression detection in the standard mhGAP-IG arm increased from 5 of 36 patients before training to 25 of 75 patients after training (AMC, 19% [95% CI, 2%-37%]), and depression detection in the e-mhGAP-IG arm increased from 6 of 35 patients before training to 67 of 76 patients after training (AMC, 71% [95% CI, 57%-85%]). In facilities in the e-mhGAP-IG arm, the app was used for 59 of 616 assessments (10% of patients) in Nepal and 883 of 1077 assessments (82% of patients) in Nigeria. Cost per patient with depression detected using the e-mhGAP-IG was Nepali Rupiya (NPR) 1980 (US $14.79) in Nepal and naira (₦) 1462 (US $0.91) in Nigeria.
Conclusions and Relevance
This feasibility cluster randomized clinical trial demonstrated that the use, cost, and potential clinical benefit of the e-mhGAP-IG varied by setting, highlighting the importance of multisite feasibility studies when evaluating digital innovations intended for health care systems worldwide.
Trial Registration
ClinicalTrials.gov Identifier: NCT04522453

Item Type: Article
Uncontrolled Keywords: mental health, detection, depression
Subjects: B Philosophy. Psychology. Religion > BF Psychology
Q Science > QA Mathematics > QA76 Computer software
R Medicine > R Medicine (General)
Faculty / School / Research Centre / Research Group: Faculty of Education, Health & Human Sciences
Faculty of Education, Health & Human Sciences > Institute for Lifecourse Development
Faculty of Education, Health & Human Sciences > Institute for Lifecourse Development > Centre for Mental Health
Faculty of Education, Health & Human Sciences > School of Health Sciences (HEA)
Last Modified: 13 Jun 2025 13:41
URI: http://gala.gre.ac.uk/id/eprint/50687

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics